ARTICLE | Company News
Axonyx, Serono deal
October 30, 2000 8:00 AM UTC
SEO completed its acquisition of exclusive worldwide rights to AXYX's amyloid and prion inhibitory peptides (see BioCentury, May 8). SEO plans to develop the peptides to treat Alzheimer's disease and ...